Omeros Corp (FRA:3O8)
€ 3.774 -0.022 (-0.58%) Market Cap: 223.44 Mil Enterprise Value: 283.18 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 51/100

Omeros Corp at UBS Global Healthcare Conference Transcript

May 22, 2019 / 12:00PM GMT
Release Date Price: €16.74 (+0.97%)
Mallet Njonkem

Good morning, everyone, and welcome to the 2019 UBS Global Healthcare Conference. My name is Mallet Njonkem, and I'm pleased to be your host this session. Please join me in welcoming our first presenter Dr. Greg Demopulos, Chairman and CEO of Omeros Corporation. There'll be a breakout session immediately following in the Uris room.

Thank you, and enjoy.

Gregory A. Demopulos
Omeros Corporation - Co-Founder, Chairman, CEO & President

Hi. Good morning, everyone. We appreciate you joining us. I'd like to thank UBS for hosting us today. As a reminder, some of the statements will be forward looking, and I refer you to our most recent 10-Q.

Sales for OMIDRIA, our marketed ophthalmic drug continue to grow, and our pipeline behind OMIDRIA continues to make significant progress. I'll provide updates on a number of these programs today as time allows. The presentation contains a lot of information, but this will be posted on our website.

Omeros now stands at about 240 employees with dozens of additional positions that we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot